Dymon Asia Capital »

United Therapeutics Corporation shares owned by Dymon Asia Capital

Quarter-by-quarter ownership of United Therapeutics Corporation (UTHR) shares owned by Dymon Asia Capital from 13F filings

Historical chart of Dymon Asia Capital investment in United Therapeutics Corporation

Tip: Access up to 7 years of quarterly data

All positions including United Therapeutics Corporation held by Dymon Asia Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in United Therapeutics Corporation by Dymon Asia Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $866k 1.5k 592.98

More positions owned by Dymon Asia Capital

State Str Spdr S&p 500 Etf T Tr Unit Call Option (SPY)
Ishares Tr Mbs Etf (MBB)
Meta Platforms Cl A (META)
NVIDIA Corporation (NVDA)
Lumentum Hldgs (LITE)
Alibaba Group Hldg Sponsored Ads (BABA)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Vaneck Etf Trust Semiconductr Etf (SMH)
Ishares Silver Tr Ishares (SLV)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Msci Sth Afr Etf Call Option (EZA)
Ishares Tr Russell 2000 Etf (IWM)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
UnitedHealth Call Option (UNH)
Microchip Technology (MCHP)

View all positions for Dymon Asia Capital

Top funds holding United Therapeutics Corporation

BlackRock
Vanguard Group
venBio Select Advisor
Wellington Management Company
Vanguard Portfolio Management
Vanguard Capital Management
State Street Corporation
Renaissance Technologies
Geode Capital Management
Caption Management
Henderson Group
Susquehanna International
AQR Capital Management
Citadel Advisors
Assetmark

View all funds holding United Therapeutics Corporation